126 related articles for article (PubMed ID: 1373459)
1. T-cell receptor gamma/delta expressing acute leukemia emerging from sideroblastic anemia: morphological, immunological, and cytogenetic features.
Meckenstock G; Fonatsch C; Heyll A; Schneider EM; Kögler G; Söhngen D; Aul C; Schneider W
Leuk Res; 1992; 16(4):379-84. PubMed ID: 1373459
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
3. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
4. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
[TBL] [Abstract][Full Text] [Related]
5. CRTAM
Ramírez-Ramírez D; Padilla-Castañeda S; Galán-Enríquez CS; Vadillo E; Prieto-Chávez JL; Jiménez-Hernández E; Vilchis-Ordóñez A; Sandoval A; Balandrán JC; Pérez-Tapia SM; Ortiz-Navarrete V; Pelayo R
J Leukoc Biol; 2019 May; 105(5):999-1013. PubMed ID: 30791148
[TBL] [Abstract][Full Text] [Related]
6. CD7+ stem cell leukemia/lymphoma. Features of a subgroup without circulating blast cells.
Katsuno M; Abe Y; Taguchi F; Yufu Y; Sadamura S; Goto T; Takatsuki H; Nishimura J; Hirata J; Akiyoshi T
Cancer; 1993 Jul; 72(1):99-104. PubMed ID: 7685244
[TBL] [Abstract][Full Text] [Related]
7. T-stem cell leukemia/lymphoma with both myeloid lineage conversion and T-specific delta recombination.
Nagano M; Kimura N; Akiyoshi T; Nishimura J; Kozuru M; Okamura J; Katsuno M; Yoshida T; Takeshita M; Tachibana K; Ohshima K; Kikuchi M
Leuk Res; 1997 Aug; 21(8):763-73. PubMed ID: 9379684
[TBL] [Abstract][Full Text] [Related]
8. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report.
Ichinohasama R; Endoh K; Ishizawa K; Okuda M; Kameoka J; Meguro K; Myers J; Kadin ME; Mori S; Sawai T
Cancer; 1996 Jun; 77(12):2592-603. PubMed ID: 8640711
[TBL] [Abstract][Full Text] [Related]
9. Human CD3 gamma delta + activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells.
Bensussan A; Lagabrielle JF; Castaigne S; Boisson N; Miclea JM; Benbunan M; Degos L
Nouv Rev Fr Hematol (1978); 1989; 31(2):129-32. PubMed ID: 2528119
[TBL] [Abstract][Full Text] [Related]
10. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
11. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
12. A new human T-cell lymphoma cell line (Karpas 384) of the T-cell receptor gamma/delta lineage with translocation t(7:14) (p13;q11.2).
Dyer MJ; Nacheva E; Fischer P; Heward JM; Labastide W; Karpas A
Leukemia; 1993 Jul; 7(7):1047-53. PubMed ID: 8391614
[TBL] [Abstract][Full Text] [Related]
13. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient.
Kawano S; Tatsumi E; Yoneda N; Yamaguchi N; Goji J; Ito H; Nagai T; Nishikori M; Okamura A; Koiwai O
Hematol Oncol; 1995; 13(1):1-11. PubMed ID: 7538482
[TBL] [Abstract][Full Text] [Related]
14. Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type.
Wong KF; Chan JK; Matutes E; McCarthy K; Ng CS; Chan CH; Ma SK
Am J Surg Pathol; 1995 Jun; 19(6):718-26. PubMed ID: 7755158
[TBL] [Abstract][Full Text] [Related]
15. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
Koyasu S
J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719
[TBL] [Abstract][Full Text] [Related]
16. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
17. Malignant T gamma/delta lymphoproliferative disease with natural killer lytic activity.
Falcão RP; Voltarelli JC; Simões BP; Pestana DN; Zago MA; Figueiredo MS
Am J Hematol; 1992 Oct; 41(2):128-31. PubMed ID: 1329501
[TBL] [Abstract][Full Text] [Related]
18. [T gamma lymphoma with CD3+ CD4- CD8- WT31- and TcR gamma delta].
Ohta C; Ohishi K; Anazawa H; Ishihara A; Sekine T; Ikeda T; Kawakami K; Ohno T; Kita K; Shirakawa S
Rinsho Ketsueki; 1990 Feb; 31(2):214-8. PubMed ID: 2139475
[TBL] [Abstract][Full Text] [Related]
19. Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens.
Matsuo Y; Drexler HG; Takeuchi M; Tanaka M; Orita K
Leuk Res; 2002 Sep; 26(9):873-9. PubMed ID: 12127564
[TBL] [Abstract][Full Text] [Related]
20. Potential antileukemic effect of gamma delta T cells in acute lymphoblastic leukemia.
Duval M; Yotnda P; Bensussan A; Oudhiri N; Guidal C; Rohrlich P; Boumsell L; Grandchamp B; Vilmer E
Leukemia; 1995 May; 9(5):863-8. PubMed ID: 7769850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
